Do Physicians Discuss Genetic Testing with Family-history-positive Breast Cancer Patients?

Connecticut Medicine

Volumn 62, Issue 1, 1998, Pages 3-7

  Polednak, Anthony P ^a  

^a Department of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; HUMAN; MIDDLE AGED; PATIENT EDUCATION; REGISTER; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONNECTICUT; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; MIDDLE AGED; PATIENT EDUCATION; REGISTRIES;

EID: 0031611319     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brower V: Testing, testing... testing? Nature Medicine 1997; 3:131-2.
2. American Society of Clinical Oncology: Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1730-6.
3. Nelson NJ: Caution guides genetic testing for hereditary cancer genes. J Natl Cancer Inst 1996;88:70-2.
4. Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 346:1409-15.
5. Zelada-Hedman M, Arver BW, Claro A, et al: A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 1997; 57:2474-7.
6. Bradbury J: Usefulness of BRCA1 and BTCA2 testing questioned. Lancet 1997; 349:1524.
7. Burke W, Press N, Pinsky L: Breast carcinoma from a primary care perspective. Cancer 1997; 80(Suppl):621-6.
8. Hofman KJ, Tambor ES, Chase GA, et al: Physicians' knowledge of genetics and genetic tests. Acad Med 1993; 68:625-32.
9. Waalen J: Genetic testing opens brave new world. Ann Intern Med 1997; 126:139-140.
10. Giardiello FM, Brensinger JD, Petersen GM, et al: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997; 336:823-7.
11. Berry DA, Parmigiani G, Sanchez J, et al: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997; 89:227-38.
12. Polednak AP, Flannery JT: Family history of breast and ovarian cancer among breast-cancer patients in the Connecticut Tumor Registry. Conn Med 1996; 60:67-70.
13. Folio Associates. Folio's Medical Directory, Connecticut and Rhode Island. 13th Ed. Hyannis Mass.: Folio Associates; 1997.
14. Gilliland FD, Larson M, Chao A: Risk factor information found in medical records of lung and prostate cancer cases, New Mexico Tumor Registry (United States). Cancer Causes Contr 1997; 8:598-604.
15. Lerman C, Biesecker B, Benkendorf JL, et al: Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997; 89:148-157.
16. Lemon SJ, Tinley ST, Fusaro RM, Lynch HT: Cancer risk assessment in a hereditary cancer prevention clinic and its first year's experience. Cancer 1997; 80(Suppl):606-13.
17. Hubbard R, Lewontin RC: Pitfalls of genetic testing. N Engl J Med 1996; 334:1192-4.
18. Nelson NJ: Studies show prophylactic surgeries seem to reduce cancer risk. J Natl Cancer Inst 1997; 89:762-3.
19. Anon: Experts in cancer genetic counseling now listed on CancerNet™. ProtoCall (Newsletter of the NCI Information Associates Program 1997:3 Fall) Bethesda, Md: National Cancer Institute Information Associates Program (1 -800-624-7890 or 301-496-7600).
20. Breast Cancer Linkage Consortium: Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997; 349: 1505-10.
21. Offit K: A new marker in the management of patients with breast cancer? Cancer 1996; 77:599-601.
22. Marcus JN, Page DL, Watson P, et al: BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer 1997; 80:543-56.